Kringle Pharma, Inc.

¥476.00As of Sun 8 Nov 2026, 12:00 UTC
TSE:4884Healthcare
Country Japan
PE (Fwd) •••
TSR 6Y CAGR (16.05%)
Div yield —
ROE (61.23%)
Biotechnology
Beta (5Y) 0.35
PE TTM —
TSR TTM 9.17%
Mkt cap ¥3.990B
ROIC (38.10%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥542
13.83%
76.73%
Hold 11|5|6|3|9
1Q26
2Q26
3Q26
4Q26
Earnings per share¥
5.90
6.14
6.34
7.05
14.77%
7.54%
16.21%
30.21%
Revenue¥M
483.1
473.4
501.3
515.2
2.55%
1.14%
6.08%
6.37%
Peers (US$25.34M)
Cap (US$)
PE
29.46M
—
22.20M
27.32x
Capital
TTM
5Y
10Y
Leveragex
0.480
(0.017)
(0.016)
EBIT/Intx
4.216
0.672
0.882
Own earn%
(66.51)
37.87
45.63
Sh yield%
42.25
44.65
43.62
Owners
Insiders/Inst%
1.21
22.61
Short interest%
1.37
SBC / revenue%
1.34
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
17
Op margin range%
20–32
$1 testx
0.0
Incr. ROIC%
−1